News

Nov 19, 2013
HD Presentation: Financial Results for the First Half of Fiscal Year Ending March 31, 2014 (PDF:1,247KB)
Nov 18, 2013
HD Notice Concerning Increase in Production Capacity for Probiotics Yogurt of Meiji Co., Ltd. (PDF:57KB)
Nov 15, 2013
HD Notice Concerning Start Chilled Milk and Yogurt Product Sales in China (PDF:168KB)
Nov 12, 2013
HD Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2014 (PDF:1,097KB)
Nov 12, 2013
HD Notice Concerning Difference between Consolidated Financial Forecasts and Actual Results for FYE March 2014 cumulative second quarter ended September 30, 2013 and Revisions to the Full-Year Consolidated Financial Forecasts (PDF:83KB)
Sep 20, 2013
HD Annual Report 2013
Aug 12, 2013
HD Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2014 (PDF:1,045KB)
July 26, 2013
PHARMA Meiji Initiates Phase 1 Clinical Trial of Arbekacin Inhalation Solution (ME1100) in the U.S. and Enters into a Licensing Agreement with PARI Pharma for a Customized eFlow® Technology Inhalation Device (PDF:99KB)
July 11, 2013
HD Notice Concerning the Consolidation of Tokai Area Distribution Centers by Meiji Co., Ltd. (PDF:25KB)
May 23, 2013
HD Presentation: Financial Results for Fiscal Year Ended March 31, 2013 (PDF:1,156KB)
May 14, 2013
HD Consolidated Financial Results for the Fiscal Year Ended March 31, 2013 (PDF:340KB)
May 14, 2013
HD Notice Concerning Differences between Consolidated Financial Forecasts and Actual Results for FYE 2013/3 (PDF:20KB)
April 18, 2013
PHARMA Meiji Initiates Phase 1 Clinical Trial of ME1111 in U.S. for Topical Treatment of Onychomycosis (PDF:99KB)
Mar 14, 2013
HD Notice Concerning Investments in Improvement of Yogurt Production System of Meiji Co., Ltd. (PDF:61KB)
Mar 4, 2013
HD We updated information for Corporate Bonds and Ratings.
Feb 13, 2013
HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2013 (PDF:242KB)